BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20140278)

  • 21. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor.
    Lee EO; Shin YJ; Chong YH
    J Neuroimmunol; 2004 Oct; 155(1-2):21-31. PubMed ID: 15342193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging roles of Wnts in the adult nervous system.
    Inestrosa NC; Arenas E
    Nat Rev Neurosci; 2010 Feb; 11(2):77-86. PubMed ID: 20010950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt signaling pathway in mammary gland development and carcinogenesis.
    Turashvili G; Bouchal J; Burkadze G; Kolar Z
    Pathobiology; 2006; 73(5):213-23. PubMed ID: 17314492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics.
    Takemaru KI; Ohmitsu M; Li FQ
    Handb Exp Pharmacol; 2008; (186):261-84. PubMed ID: 18491056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the Wnt/beta-catenin network in regulating hematopoiesis.
    Wilusz M; Majka M
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells.
    de Melker AA; Desban N; Duband JL
    Dev Dyn; 2004 Aug; 230(4):708-26. PubMed ID: 15254905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-catenin in the race to fracture repair: in it to Wnt.
    Silkstone D; Hong H; Alman BA
    Nat Clin Pract Rheumatol; 2008 Aug; 4(8):413-9. PubMed ID: 18560386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.
    Salins P; Shawesh S; He Y; Dibrov A; Kashour T; Arthur G; Amara F
    Neurosci Lett; 2007 Feb; 412(3):211-6. PubMed ID: 17234346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for an enhancement of excitatory transmission in adult CNS by Wnt signaling pathway modulation.
    Beaumont V; Thompson SA; Choudhry F; Nuthall H; Glantschnig H; Lipfert L; David GR; Swain CJ; McAllister G; Munoz-Sanjuan I
    Mol Cell Neurosci; 2007 Aug; 35(4):513-24. PubMed ID: 17588772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt signaling: role in LTP, neural networks and memory.
    Oliva CA; Vargas JY; Inestrosa NC
    Ageing Res Rev; 2013 Jun; 12(3):786-800. PubMed ID: 23665425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.
    Liu L; Wan W; Xia S; Kalionis B; Li Y
    Neurochem Int; 2014 Sep; 75():19-25. PubMed ID: 24859746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Involvement of Wnt signaling in hippocampal plasticity].
    Markevich VA; Salozhin SV; Guliaeva NV
    Ross Fiziol Zh Im I M Sechenova; 2012 Dec; 98(12):1460-70. PubMed ID: 23461192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt signaling: role in Alzheimer disease and schizophrenia.
    Inestrosa NC; Montecinos-Oliva C; Fuenzalida M
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):788-807. PubMed ID: 23160851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt/β-catenin signaling in Alzheimer's disease.
    De Ferrari GV; Avila ME; Medina MA; Perez-Palma E; Bustos BI; Alarcon MA
    CNS Neurol Disord Drug Targets; 2014; 13(5):745-54. PubMed ID: 24365184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt signaling during synaptic development and plasticity.
    Budnik V; Salinas PC
    Curr Opin Neurobiol; 2011 Feb; 21(1):151-9. PubMed ID: 21239163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A Role of the Wnt Signaling in the Regulation of Brain Function].
    Gurskaya OY; Dobryakova YV; Markevich VA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2015; 65(4):387-99. PubMed ID: 26601498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt signaling in the nervous system and in Alzheimer's disease.
    Inestrosa NC; Varela-Nallar L
    J Mol Cell Biol; 2014 Feb; 6(1):64-74. PubMed ID: 24549157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges.
    Serafino A; Giovannini D; Rossi S; Cozzolino M
    Expert Opin Drug Discov; 2020 Jul; 15(7):803-822. PubMed ID: 32281421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.